<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>BACKGROUND AND PURPOSE: To investigate the clinical relevance of plasma concentrations of neuron-specific enolase (NSE) in patients with severe cerebrovascular diseases, serial analyses were performed during the first 10 days after the <z:hpo ids='HP_0011009'>acute</z:hpo> event </plain></SENT>
<SENT sid="1" pm="."><plain>METHODS: Plasma samples taken from 61 patients (30 with <z:e sem="disease" ids="C0751955" disease_type="Disease or Syndrome" abbrv="">brain infarction</z:e>, 13 with <z:hpo ids='HP_0001342'>intracerebral hemorrhage</z:hpo>, 11 with cardiogenic <z:mp ids='MP_0005039'>hypoxia</z:mp>-<z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e>, and 7 with <z:hpo ids='HP_0001658'>myocardial infarction</z:hpo> [as control group]) were analyzed for NSE concentration using an enzyme immunoassay </plain></SENT>
<SENT sid="2" pm="."><plain>The time course of plasma NSE was correlated with clinical findings, clinical outcome, cranial computed tomography, intracranial pressure, and other laboratory data </plain></SENT>
<SENT sid="3" pm="."><plain>RESULTS: In cases of <z:mp ids='MP_0005039'>hypoxia</z:mp>-<z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> there was close correlation between plasma NSE values during the first 72 hours and the clinical outcome </plain></SENT>
<SENT sid="4" pm="."><plain>In <z:e sem="disease" ids="C0751955" disease_type="Disease or Syndrome" abbrv="">brain infarction</z:e> and <z:hpo ids='HP_0001342'>intracerebral hemorrhage</z:hpo>, high plasma NSE mostly indicated an unfavorable outcome, but low values did not permit a reliable prognostic estimation </plain></SENT>
<SENT sid="5" pm="."><plain>In cases of <z:e sem="disease" ids="C0007785" disease_type="Disease or Syndrome" abbrv="">cerebral infarction</z:e> and <z:hpo ids='HP_0001342'>intracerebral hemorrhage</z:hpo> with secondary neuronal destruction (for example, due to malignant <z:hpo ids='HP_0000969'>edema</z:hpo>), increasing NSE concentrations in plasma preceded the change of clinical or other diagnostic parameters </plain></SENT>
<SENT sid="6" pm="."><plain>CONCLUSIONS: The course of plasma NSE levels is seen as a relevant parameter for assessing the prognosis of cerebral <z:mp ids='MP_0005039'>hypoxia</z:mp>-<z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> </plain></SENT>
<SENT sid="7" pm="."><plain>Additionally, it may prove to be a useful tool for monitoring space-occupying <z:e sem="disease" ids="C0751955" disease_type="Disease or Syndrome" abbrv="">brain infarctions</z:e> and <z:hpo ids='HP_0001342'>intracerebral hemorrhages</z:hpo> and therefore may contribute to improved therapeutic management of severe cerebrovascular diseases </plain></SENT>
</text></document>